Last reviewed · How we verify

NCT07428278: ROCKS

Resilience-Building for Advance Care Planning

Not yet recruiting NA Last updated 23 February 2026
What this trial tests

NA trial testing ROCKS in Advanced Cancer in 152 participants. Not yet recruiting.

Timeline
20 March 2026
Primary endpoint
31 May 2028
31 July 2028

Quick facts

Lead sponsorUniversity of Illinois at Chicago
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment152
Start date20 March 2026
Primary completion31 May 2028
Estimated completion31 July 2028

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Chicago

Who can join

Adults 18 to 80, any sex, with Advanced Cancer or End of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study are to (1) assess the feasibility, acceptability, and usability of the ROCKS intervention among patients with advanced cancer and their family caregivers through a randomized controlled trial in a cancer center setting; (2) evaluate the preliminary efficacy of ROCKS, as compared to usual care, on changes in completion of advance directives; and (3) explore the dyadic effects of resilience on self-efficacy, optimism, dyadic communication and coping, anxiety, and depression using an actor-partner interdependence model.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Advanced Cancer

Currently open trials in the same condition.

Other University of Illinois at Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07428278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing